Bachem Holding AG

Common Name
Bachem Holding
Country
Switzerland
Sector
Basic Materials
Industry
Chemicals
Employees
2,292
Ticker
BANB
Exchange
SIX SWISS EXCHANGE
Description
Bachem Holding AG is a prominent name in the biotechnology and pharmaceutical industry, specializing in the development and manufacture of peptides and oligonucleotides. These are complex organic comp...

Financial Statements of Bachem Holding

Below are the financial statements of Bachem Holding, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of CHF
2024 2024-01-01 - 2024-12-31
2023 2023-01-01 - 2023-12-31
Net sales
605.26a
577.32a
Cost of goods sold
-422.7a
-400.35a
Gross profit
182.56a
176.96a
Other income
1.11a
0.82a
Marketing and sales costs
-17.42a
-17.96a
Research and development costs
-11.38a
-11.04a
General administrative costs
-21.82a
-19.4a
Operating income (EBIT)
133.05a
129.38a
Financial income
11.51a
6.34a
Financial expenses
-9.3a
-11.01a
Ordinary income
135.26a
124.71a
Extraordinary result
-0.05a
-0.5a
Income before taxes
135.21a
124.21a
Income taxes
-14.96a
-12.35a
Net income
120.25a
111.86a
Download Data

Verified Sources Behind Bachem Holding’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Bachem Holding’s data sources below and access millions more through our Disclosure Search.

a. Bachem Holding's Annual Report 2024
a. Bachem Holding's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?